September 25, 2015. If you’re an angel investor and aren’t yet well-versed in syndication, now is the time to take notice. The changing math required to fund promising...

The Australian, September, 18, 2015. Australia’s neuroscience expertise has convinced US company Cognition Therapeutics to launch a clinical study of a new Alzheimer’s drug in...

Scale Angels investee company Cognition Therapeutics commences clinical trials in Melbourne  Friday 18th September 2015. Cognition Therapeutics Inc. (CogRx), a privately held...

PITTSBURGH, Sept. 8, 2015 /PRNewswire/ — Cognition Therapeutics Inc. (CogRx), a privately held pharmaceutical company focused on discovering and developing disease-modifying...